Home About us Contact
|
Home About us Contact | ||
|
|
||
Laboratories Worldwide (laboratory + worldwide)
Selected AbstractsQuality control of CD4+ T-lymphocyte enumeration: Results from the last 9 years of the United Kingdom national external quality assessment scheme for immune monitoring (1993,2001)CYTOMETRY, Issue 2 2002Liam Whitby Abstract The human immunodeficiency virus (HIV) global epidemic has necessitated the routine enumeration of T-lymphocyte subsets, which has created a need for external quality assurance (EQA). The United Kingdom National External Quality Assessment Scheme (UK NEQAS) for Immune Monitoring provides EQA for 296 laboratories in 40 countries. In 1993, UK NEQAS developed and incorporated into its program stabilized whole blood that enables the accurate monitoring of laboratory performance. Overall, the mean interlaboratory coefficient of variation (CV) for percentage CD4+ T-lymphocyte subset enumeration has fallen from 15% to less than 5%, as a direct result of the increased use of CD45/ side scatter (SSC) gating. Laboratories using alternative gating strategies (i.e., CD45/CD14 or forward scatter [FSC]/SSC) were about 7.4 times more likely to fail an EQA exercise. Furthermore, the adoption of single-platform technology resulted in a reduction of the overall mean interlaboratory CV for absolute CD4+ T lymphocytes from 56% (prior to the widespread use of single-platform technology) to 9.7%. Individual laboratory deficiencies were also identified using a performance monitoring system and, through re-education by collaboration with the coordinating center, satisfactorily resolved. In conclusion, during the last 9 years, the UK NEQAS for Immune Monitoring program has highlighted the significant technological advances made by laboratories worldwide that undertake lymphocyte subset enumeration. Cytometry (Clin. Cytometry) 50:102,110, 2002. © 2002 Wiley-Liss, Inc. [source] The past, present, and future of chemometrics worldwide: some etymological, linguistic, and bibliometric investigations,JOURNAL OF CHEMOMETRICS, Issue 6-7 2006R. Kiralj Abstract Internet surfing for the word chemometrics in national languages and, in the Science Citation Index (SCI), searching for articles containing chemometr * were performed. The bibliometric, webometric, and country development descriptors from literature were then treated by Principal Component Analysis (PCA) and Hierarchical Cluster Analysis (HCA). In total, 82 written and 127 pronunciation forms of chemometrics were found in 48 languages worldwide. The forms ending in ,- y' (chemometry) and ,- ics' (chemometrics) can be grouped into at least three groups (I, J, K). Scientific collaboration, country development, geography, history, and language were shown to be important determinants in creation of form(s) of chemometrics in a particular country or language. PCA and HCA show that tradition in chemometrics, level of country development, and its scientific production are important for the existence of chemometric societies and laboratories worldwide. Today, the world tends toward becoming more homogeneous with respect to chemometric activity, and will reach a corresponding normal distribution in about 70 years from now. Copyright © 2007 John Wiley & Sons, Ltd. [source] Three-Dimensional Surface Topography Acquisition and Analysis for Firearm IdentificationJOURNAL OF FORENSIC SCIENCES, Issue 2 2006Nicola Senin M.S. ABSTRACT: In the last decade, computer-based systems for the comparison of microscopic firearms evidence have been the subject of considerable research work because of their expected capability of supporting the firearms examiner through the automated analysis of large amounts of evidence. The Integrated Ballistics Identification System, which is based on a two-dimensional representation of the specimen surface, has been widely adopted in forensic laboratories worldwide. More recently, some attempts to develop systems based on three-dimensional (3D) representations of the specimen surface have been made, both in the literature and as industrial products, such as BulletTRAX-3D, but fundamental limitations in achieving fully automated identification remain. This work analyzes the advantages and disadvantages of a 3D-based approach by proposing an approach and a prototype system for firearms evidence comparison that is based on the acquisition and analysis of the 3D surface topography of specimens, with particular reference to cartridge cases. The concept of 3D virtual comparison microscope is introduced, whose purpose is not to provide fully automated identification, but to show how the availability of 3D shape information can provide a whole new set of verification means, some of them being described and discussed in this work, specifically, visual enhancement tools and quantitative measurement of shape properties, for supporting, not replacing, the firearm examiner in reaching the final decision. [source] Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospectsPRENATAL DIAGNOSIS, Issue 2 2009Geoff Daniels Abstract Fetuses of women with alloantibodies to RhD (D) are at risk from hemolytic disease of the fetus and newborn, but only if the fetal red cells are D-positive. In such pregnancies, it is beneficial to determine fetal D type, as this will affect the management of the pregnancy. It is possible to predict, with a high level of accuracy, fetal blood group phenotypes from genotyping tests on fetal DNA. The best source is the small quantity of fetal DNA in the blood of pregnant women, as this avoids the requirement for invasive procedures of amniocentesis or chorionic villus sampling (CVS). Many laboratories worldwide now provide noninvasive fetal D genotyping as a routine service for alloimmunized women, and some also test for c, E, C and K. In many countries, anti-D immunoglobulin injections are offered to D-negative pregnant women, to reduce the chances of prenatal immunization, even though up to 40% of these women will have a D-negative fetus. High-throughput, noninvasive fetal D genotyping technologies are being developed so that unnecessary treatment of pregnant women can be avoided. Trials suggest that fetal D typing of all D-negative pregnant women is feasible and should become common practice in the near future. Copyright © 2008 John Wiley & Sons, Ltd. [source] | |||||||||||||